(1S)-1-diethoxyphosphoryl-2-ethenylcyclopropan-1-amine | 922164-24-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机膦酸及其衍生物
• 英文名称: (1S)-1-diethoxyphosphoryl-2-ethenylcyclopropan-1-amine
• CAS: 922164-24-7
• 化学式: C₉H₁₈NO₃P
• 分子量: 219.221
• InChiKey: PYAPLGZAWBFCRA-GKAPJAKFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  61.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(2-cyclopentyloxycarbonylamino-3,3-dimethyl-butyryl)-4-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-pyrrolidine-2-carboxylic acid 、 (1S)-1-diethoxyphosphoryl-2-ethenylcyclopropan-1-amine 在 N-甲基吗啉 、 HATU 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 以70%的产率得到
  参考文献：
  名称：

  Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors

  摘要：

  A novel class of phosphonate derivatives was designed to mimic the interaction of product-like carboxylate based inhibitors of HCV NS3 protease. A phosphonic acid (compound 2) was demonstrated to be a potent HCV NS3 protease inhibitor, and a potential candidate for treating HCV infection. The syntheses and preliminary biological evaluation of this phosphonate class of inhibitor are described. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.023
• 作为产物：
  描述：

  在 碳酸氢钠 作用下， 以 二氯甲烷 为溶剂， 以100%的产率得到(1S)-1-diethoxyphosphoryl-2-ethenylcyclopropan-1-amine
  参考文献：
  名称：

  Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors

  摘要：

  A novel class of phosphonate derivatives was designed to mimic the interaction of product-like carboxylate based inhibitors of HCV NS3 protease. A phosphonic acid (compound 2) was demonstrated to be a potent HCV NS3 protease inhibitor, and a potential candidate for treating HCV infection. The syntheses and preliminary biological evaluation of this phosphonate class of inhibitor are described. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.023

文献信息

• Antiviral Compounds
  申请人：Chaudhary Kleem

  公开号：US20080311077A1

  公开（公告）日：2008-12-18

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  该发明涉及磷取代的抗病毒抑制化合物，含有这种化合物的组合物和包括该化合物的治疗方法，以及用于制备这种化合物的过程和中间体。
• Antiviral compounds
  申请人：GILEAD SCIENCES, INC.

  公开号：EP2316839A1

  公开（公告）日：2011-05-04

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  本发明涉及磷取代的抗病毒抑制化合物、含有此类化合物的组合物、包括施用此类化合物的治疗方法，以及制备此类化合物的工艺和中间体。
• WO2007/11658
  申请人：——

  公开号：——

  公开（公告）日：——
• US7642339B2
  申请人：——

  公开号：US7642339B2

  公开（公告）日：2010-01-05
• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：GILEAD SCIENCES INC

  公开号：WO2006020276A2

  公开（公告）日：2006-02-23

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.